lactate threshold-based incremental treadmill training and assessment protocol (LACTOC) for managing treatment-induced cardiotoxicity in oncology patients
Authors:
- Alejandro Soler-LópezAlejandro Soler-López
- Laura Herrero-VidalLHLaura Herrero-Vidal
- Daniel González-DevesaDGDaniel González-Devesa
- Daniel López-PlazaDLDaniel López-Plaza
- Rubén Toledo-PozueloRTRubén Toledo-Pozuelo
- Alberto González-CosteaAGAlberto González-Costea
- Carlos D. Gómez-CarmonaCarlos D. Gómez-Carmona
Open Access
- 18 March 2026
- journal article
- Published by Asociacion Espanola de Analisis del Rendimiento Deportivo in Physical Activity, Exercise and Cancer
- Vol. 3 (2) , 87-100
Abstract
Cardiotoxicity represents a clinically significant complication in oncology patients, manifesting as cardiac dysfunction that impairs functional capacity and quality of life. Physical exercise has emerged as a promising intervention to mitigate treatment-related adverse effects; however, optimal exercise prescription for patients with cardiotoxicity remains poorly defined, as most existing protocols rely on heart rate percentages or peak oxygen consumption—methods imprecise in cardiovascularly compromised populations. This protocol describes the LACTOC program, a 4-week supervised treadmill exercise intervention comprising 12 sessions (three per week, 48-hour recovery intervals) in oncology patients with treatment-induced cardiotoxicity. Each session includes a warm-up (5 min at 3 km/h), a progressive incremental test with 3-minute stages and 1 km/h increments from 4 km/h until reaching 4 mmol/L blood lactate or 85% of theoretical maximal heart rate, and active recovery (5 min at 3 km/h). Comprehensive cardiovascular, metabolic, perceptual, and heart rate variability monitoring is integrated throughout. The protocol is expected to enable individualized exercise prescription based on objective metabolic thresholds, with session-by-session load adjustment guided by daily HRV assessment representing a methodological advance over conventional fixed-prescription approaches. This proposal is positioned as a promising framework for cardio-oncological rehabilitation, providing objective tools to guide safe and effective exercise prescription in patients with treatment-induced cardiotoxicity.Keywords
This publication has 31 references indexed in Scilit:
- Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exerciseJournal of Cancer Research and Clinical Oncology, 2025
- Exercise, cancer, and the cardiovascular system: clinical effects and mechanistic insightsBasic Research in Cardiology, 2024
- Exercise intensity prescription in cancer survivors: ventilatory and lactate thresholds are useful submaximal alternatives to VO2peakSupportive Care in Cancer, 2020
- End-of-Life Care in Patients With Heart FailureJournal of Cardiac Failure, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Training Adaptation and Heart Rate Variability in Elite Endurance Athletes: Opening the Door to Effective MonitoringSports Medicine, 2013
- Individual differences in the responses to endurance and resistance trainingEuropean Journal of Applied Physiology, 2005
- ACC/AHA 2002 guideline update for exercise testing: summary articleJACC, 2002
- Impaired Chronotropic Response to Exercise Stress Testing as a Predictor of MortalityJAMA, 1999
- A 1% treadmill grade most accurately reflects the energetic cost of outdoor runningJournal of Sports Sciences, 1996